Elon Musk declined to comment on NYT report on his drug use

Elon Musk declined to comment on NYT report on his drug use

Elon Musk has been under scrutiny following a New York Times report detailing his extensive drug use while serving as a close advisor to former President Donald Trump. The report, published on May 30, 2025, revealed that Musk regularly consumed ketamine, ecstasy, and psychedelic mushrooms, sometimes on a daily basis, during his tenure at the White House. Musk's drug use reportedly caused health issues, including bladder problems, and may have impacted his performance at the Department of Government Efficiency (DOGE), where he served as a "Special Government Employee."

The New York Times investigation, citing anonymous sources, indicated that Musk's drug use intensified as he donated $275 million to Trump's presidential campaign and held significant power within the Trump administration. Musk's drug use was reportedly a closely guarded secret, with associates describing his ketamine habit as a serious one, leading to concerns about his ability to perform his duties effectively.

Musk has not commented on the report, which has raised questions about his mental state and the potential impact of his drug use on his business ventures and political influence. The report also highlights the potential legal and ethical implications of Musk's actions, given his role in advising the president and his access to classified information.

The drug use allegations come at a critical time for Musk, as he has been facing internal strife and legal challenges during his brief tenure at DOGE. Musk's departure from the agency, announced on May 28, 2025, marks the end of his controversial 130-day term as a "Special Government Employee." His tenure was marked by cost savings through layoffs and tech integration but was also characterized by legal backlash and limited measurable success.

The implications of Musk's drug use for his business reputation and future political involvement remain uncertain. Investors and financial professionals are closely watching the situation, as Musk's actions could potentially impact his companies, including SpaceX and Tesla. The report highlights the importance of ethical behavior and transparency in leadership roles, particularly those with significant political and business influence.

References:
[1] https://www.usatoday.com/story/life/health-wellness/2025/05/30/elon-musk-ketamine-trump-campaign/83942817007/
[2] https://www.theguardian.com/us-news/2025/may/30/elon-musk-trump-drug-use
[3] https://timesofindia.indiatimes.com/technology/tech-news/elon-musk-exits-doge-inside-the-chaotic-end-of-elons-2-trillion-government-mission/articleshow/121497428.cms